Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 2/20 | 0.54 |
| ▸ | PDE4B | Q07343 | 10/20 | 0.53 |
| ▸ | PDE4A | P27815 | 1/20 | 0.53 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.53 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.53 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6837108 | 0.99 | PDE4D (0.55) | PDE4DPDE4BPDE4APDE4CPDE3B | |
| SCHEMBL6656363 | 0.94 | PDE4D (0.60) | PDE4DPDE4BPDE4APDE4CPDE3B | |
| SCHEMBL6654260 | 0.94 | PDE4D (0.53) | PDE4DPDE4BPDE4APDE4CPDE3B | |
| SCHEMBL6663295 | 0.94 | PDE4D (0.61) | PDE4DPDE4BPDE4APDE4CPDE3B | |
| SCHEMBL6677316 | 0.93 | PDE4D (0.53) | PDE4DPDE4BPDE4APDE4CPDE3B | |
| SCHEMBL6842550 | 0.92 | PDE4D (0.53) | PDE4DPDE4BPDE4APDE4CPDE3B | |
| SCHEMBL6660127 | 0.92 | PDE4D (0.66) | PDE4DPDE4BPDE4APDE4CPDE3B | |
| SCHEMBL6659073 | 0.92 | PDE4D (0.56) | PDE4DPDE4BPDE4APDE4CPDE3B | |
| SCHEMBL6660131 | 0.92 | PDE4D (0.52) | PDE4DPDE4BPDE4APDE4CPDE3B | |
| SCHEMBL6655157 | 0.91 | PDE4D (0.56) | PDE4DPDE4BPDE4APDE4CPDE3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040235845-A1 | Use of phosphodiesterase iv inhibitors | MERCK PATENT GESSELSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2004-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235845-A1 | Use of phosphodiesterase iv inhibitors | PDE4A, PDE3A, PDE3B | PDE4D 12/4885PDE4B 4/4885PDE4A 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.